Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

UroGen Pharma Appoints Liz Barrett as Chief Executive Officer

PUBLIC · URGNOct 18, 2026
New to company · from Novartis“Barrett previously led oncology activities at Novartis”

Position

Chief Executive Officer

Company

UroGen Pharma

Liz Barrett
liz.barrett@urogen.com
PrincetonBiotechnologyHealthcare

Description

UroGen Pharma has appointed Liz Barrett as chief executive officer, effective October 18, 2026. Barrett brings extensive experience from her role in leading oncology activities at Novartis, enhancing UroGen's commitment to its urothelial cancer pipeline.

Company Information

Company

UroGen Pharma

Location

400 Alexander Park Drive

Princeton, New Jersey, United States

About

UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options. Our vision is grounded in our RTGel® drug delivery technology, our promising pipeline, and a collaborative drive for bold results.

Fundz sees it the moment UroGen Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Kate
Senior decision-maker at this company
••••••••@••••••••

See Kate's verified email →

Eric
Likely contact at this company
••••••••@••••••••

See Eric's verified email →

Gary
Likely contact at this company
••••••••@••••••••

See Gary's verified email →

Liz
Likely contact at this company
••••••••@••••••••

See Liz's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for UroGen Pharma's next move

Learn about Strategic plan

UroGen Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.